Patrick Mccarthy, PHARMD | |
485 Arsenal St, Watertown, MA 02472-5091 | |
(617) 972-5100 | |
Not Available |
Full Name | Patrick Mccarthy |
---|---|
Gender | Male |
Speciality | Pharmacist - Ambulatory Care |
Location | 485 Arsenal St, Watertown, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255848123 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P2201X | Pharmacist - Ambulatory Care | PH237459 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Patrick Mccarthy, PHARMD 485 Arsenal St, Watertown, MA 02472-5091 Ph: () - | Patrick Mccarthy, PHARMD 485 Arsenal St, Watertown, MA 02472-5091 Ph: (617) 972-5100 |
News Archive
The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
Lightpoint Medical, a clinical-stage medical device company developing advanced imaging technologies for intraoperative cancer detection, announced today that the company has signed an exclusive global license agreement for a molecular imaging technology called Beta Emission Tomography, developed by Professor Harrison Barrett, Regents Professor of Radiology and Optical Science, with his student Yijun Ding and colleague Dr. Luca Caucci at the University of Arizona Center for Gamma Ray Imaging.
More than an estimated 160,000 people in the United States will die from lung cancer this year, making it the country's leading cause of cancer death. According to the National Cancer Institute, it surpassed breast cancer as the number one killer in women back in 1987. It causes more deaths than colon, breast and prostate cancer combined, according to the American Lung Association. Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.
Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification of oncogenic ALK, RET, and ROS1 gene fusions in non-small cell lung cancer tumors.
› Verified 2 days ago
Aruranie Ramjeawan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Arsenal St, T-1442, Watertown, MA 02472 Phone: 617-924-5987 Fax: 617-924-5987 | |
Vekcheth Houm, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27 Main St, Watertown, MA 02472 Phone: 617-926-6660 | |
Dr. Amy Tam, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Arsenal St, T-1442, Watertown, MA 02472 Phone: 617-924-5987 | |
Dr. Leanne Nicole Taylor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Arsenal St, Watertown, MA 02472 Phone: 617-924-5987 | |
Danielle Nemtsev, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Watertown St, Watertown, MA 02472 Phone: 617-332-5528 | |
Bryce Foote, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Arsenal St, T-1442, Watertown, MA 02472 Phone: 617-924-5987 | |
Mary Lo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 Mount Auburn St, Watertown, MA 02472 Phone: 617-744-0842 |